Witness· Pfizer
Shane Weber
Former Pfizer diagnostics director who evaluated a proposed use for Theranos technology.
AppearedFederal Criminal Trial
395 lines·3 appearances·11 mentions
About
Described Pfizer's 2008 due diligence on Theranos and testified that it produced no recommendation for further investment or clinical support. He rejected later claims that Pfizer had validated or endorsed Theranos technology and denied authorizing Pfizer's logo on the cited materials.
Trial Record (14)
FederalFederal Criminal TrialAug 31, 2021 – Jan 3, 2022
Testimony (3)
Mentioned (11)
Procedural
Trial Scheduling and Preliminary Matters
Day 21ProceduralAdmissibility Hearing — Pfizer Internal Report
Day 21CrossDaniel Edlin — Cross
Day 21ProceduralText-Message Admissibility Ruling
Day 22ProceduralAdmissibility Hearing on Dr. Weber's Pfizer Report
Day 22ProceduralEnd-of-Day Jury Admonition
Day 22ProceduralPretrial Evidentiary Conference on Tolbert Exhibits
Day 23ProceduralRuling on Shane Weber Report (Exhibit 167)
Day 23ProceduralMotion in Limine Hearing on Roger Parloff Testimony
Day 29DirectElizabeth A. Holmes — Direct
Day 38ClosingClosing Argument by the Defense
Day 46